News Wire

Researchers have identified a vital supply route that cancer cells use to obtain their nutrients—a discovery that could lead to new treatments to stop the growth of tumors.   The research team blocked gateways through which the cancer cell was obtaining the amino acid glutamine and found the cells…
Supervised, autonomous robotic soft tissue surgery on a live subject in an open surgical setting is feasible and outperforms standard clinical techniques in a dynamic clinical environment, a new study shows. The study, involving surgeons and scientists from Sheikh Zayed Institute for Pediatric Surgical…
The FDA is warning that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of the antipsychotic drug aripiprazole (Abilify, Abilify Maintena, Aristada, and generics). These uncontrollable urges were reported to have stopped when the medicine was…
Cook Medical has recalled more than four million catheters with Beacon Tip technology that have been found to exhibit polymer degradation of the catheter tip, resulting in tip fracture, separation, or both. The problem has resulted in 30 medical device reports to date. Potential adverse events that…
The FDA has granted priority review to the biologics license application (BLA) for olaratumab (Eli Lilly and Company) in combination with doxorubicin for the potential treatment of people with advanced soft tissue sarcoma (STS) not amenable to curative treatment with radiotherapy or surgery. Olaratumab,…
The survival rate of patients with hepatitis C virus–related cirrhosis who respond well to antiviral therapies equals that of the general population, investigators write in the Journal of Hepatology. Long-term development of cirrhosis and liver disorders, such as decompensation or hepatocellular carcinoma,…
Johns Hopkins patient safety experts calculate that more than 250,000 U.S. deaths per year are due to medical errors. Their analysis, based on medical death rate data over an eight-year period, was published May 3 in the BMJ. The figure they reached surpasses the third leading cause of death listed…
GlaxoSmithKline (GSK) released data today from a new national survey that shows that 67% of adults with uncontrolled asthma in the U.S. are living with the misperception that their condition is under control. The survey results may suggest uncontrolled patients feel a false sense of confidence in managing…
Biogen Inc. has announced that it intends to spin off its hemophilia business as an independent, publicly traded company. “We expect that the new company will be a leader in discovering, developing, and commercializing innovative therapies for hemophilia, built on remarkable science and a deep understanding…
At least 30% of antibiotics prescriptions in the United States are unnecessary, according to new data published today in the Journal of the American Medical Association by the Centers for Disease Control and Prevention (CDC) in collaboration with Pew Charitable Trusts and other public health and medical…
In a study of nearly 650 people with age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read standard print, after five years of treatment with anti-VEGF drugs that are injected into the eye. The authors of the study, funded by the National…
The number of new HIV infections and the transmission rate in the United States dropped by 11% and 17%, respectively, between 2010 and 2015, but fell short of the goals put forth by President Obama’s U.S. National HIV/AIDS Strategy (NHAS), researchers from the Perelman School of Medicine at the University…
The FDA has approved the first generic version of Crestor tablets (rosuvastatin calcium, AstraZeneca), which will be marketed by Allergan in 5-, 10-, 20-, and 40-mg strengths. The drug is approved for use in combination with diet for the treatment of high triglycerides (hypertriglyceridemia) in adults; in…
Regeneron Pharmaceuticals has announced positive topline results from a placebo-controlled phase 2/3 study evaluating fasinumab in patients with moderate-to-severe osteoarthritis pain of the hip or knee who have a history of inadequate pain relief or intolerance to current analgesic therapies. At 16…
Pimavanserin (Nuplazid, Acadia Pharmaceuticals) has received FDA approval for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. In 2014, the FDA designated pimavanserin as a breakthrough therapy for this condition. “Today’s approval of Nuplazid represents…

Pages